Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Dean Foods announces sale of operations to Dairy Farmers of America
Davis Polk is advising Dean Foods Company on the acquisition by Dairy Farmers of America of a substantial portion of Dean…
Symphony Technology consortium $2.075 billion acquisition of RSA from Dell
Davis Polk is advising a consortium led by Symphony Technology Group on its approximately $2.075 billion acquisition of RSA…
RXR Realty $131 million loan for mixed-use development in New Rochelle, NY
We advised affiliates of RXR Realty on the construction financing
Dean Foods announces sale of operations to Dairy Farmers of America
Davis Polk is advising Dean Foods Company on the acquisition by Dairy Farmers of America of a substantial portion of Dean…
RXR Realty $131 million loan for mixed-use development in New Rochelle, NY
We advised affiliates of RXR Realty on the construction financing
Revolution Medicines $273.7 million IPO
Davis Polk advised the underwriters in connection with an initial public offering of 16,100,000 shares of common stock of…
Symphony Technology consortium $2.075 billion acquisition of RSA from Dell
Davis Polk is advising a consortium led by Symphony Technology Group on its approximately $2.075 billion acquisition of RSA…
Symphony Technology consortium $2.075 billion acquisition of RSA from Dell
Davis Polk is advising a consortium led by Symphony Technology Group on its approximately $2.075 billion acquisition of RSA…
Symphony Technology consortium $2.075 billion acquisition of RSA from Dell
Davis Polk is advising a consortium led by Symphony Technology Group on its approximately $2.075 billion acquisition of RSA…
Revolution Medicines $273.7 million IPO
Davis Polk advised the underwriters in connection with an initial public offering of 16,100,000 shares of common stock of…